Hong Kong gets Pfizer-BioNTech vaccines as 2nd option
28 February, 2021
More than 500,000 doses of the Pfizer-BioNTech vaccine arrived in Hong Kong on Saturday (Feb 27) carrying out a two-day delay because of export procedures, offering a second inoculation alternative for the city.
The Pfizer-BioNTech shots will be wanted to about 2.4 million eligible residents from priority organizations such as for example those aged 60 and above and health care workers.
The 585,000 doses of the vaccine - the first batch of the initial 1 million - arrived from Germany. The remaining doses will be sent in early March, relating to a authorities statement.
About 70,000 people who've registered for Hong Kong’s vaccination programme, which kicked off on Friday, will receive the shots produced by Chinese biopharmaceutical firm Sinovac. The Sinovac vaccines had been the first ever to arrive last week.
About 6,000 persons have been completely injected with the Sinovac vaccine. Registration details for all those wishing to have the Pfizer-BioNTech shots have not been announced.
Hong Kong has struck offers for a complete of 22.5 million doses, with 7.5 million each from Sinovac, AstraZeneca and Fosun Pharma, which is delivering the Pfizer-BioNTech vaccines. The government has so far permitted the Sinovac and Pfizer-BioNTech vaccines.
Source: